Dietary Strategies and Nutritional Management in Patients Receiving GLP ‐1 and Dual GIP / GLP ‐1 Receptor Agonists as Adjuncts to Lifestyle Interventions: A Systematic Review of Randomised Clinical Trials

Documenti analoghi

• Safety of GLP ‐1 and Dual GLP ‐1/ GIP Receptor Agonists in Preconception, Pregnancy, and Lactation: A Systematic Review of Maternal, Fetal, and Neonatal Outcomes
  di: Lasin Ozbek, et al.
  Pubblicazione: (2026)
• Interpreting Pregnancy Risk After GLP ‐1 Receptor Agonists Discontinuation
  di: Roberta Scairati, et al.
  Pubblicazione: (2026)
• Impact of GLP ‐1 Receptor Agonist Discontinuation on Liver‐Related Parameters: A Systematic Review and Meta‐Analysis
  di: Matheus Souza, et al.
  Pubblicazione: (2026)
• GLP ‐1 Receptor Agonists and Psychiatric Outcomes in Adolescents: A Systematic Review and Meta‐Analysis
  di: Cynthia F. X. C. A. Silva, et al.
  Pubblicazione: (2026)
• Association of GLP ‐1 Receptor Agonists With Hepatic Decompensation in the All of Us Research Program
  di: Inyoung Hwang, et al.
  Pubblicazione: (2026)